IMM 3.51% 27.5¢ immutep limited

Ann: Immutep advances its LAG-3 agonist for autoimmune diseases, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,931 Posts.
    lightbulb Created with Sketch. 13
    https://www.fiercebiotech.com/research/study-t-cell-counts-covid-19-patients-offers-clues-about-why-roche-s-actemra-might-work?mkt_tok=eyJpIjoiT1dGak5qZGhNMkptWkRKbCIsInQiOiJrXC94ZXF2WTU2TkNiendaYzVpcmxiR0oxTzVLaDF3c1wvRG1jWTZYcld4WXNFSnFLbGxiaGdFTlFyeThjcHEzeW5IWVVjT2pDamNVaFVlV01OVmlIa3dvdmRmZENRUVVJTk1vbjlGanhNcDU3d3E2YW5PbTJ4dWpXMlFaanp0UVcxIn0%3D&mrkid=981295

    https://www.fiercebiotech.com/research/study-t-cell-counts-covid-19-patients-offers-clues-about-why-roche-s-actemra-might-work?mkt_tok=eyJpIjoiT1dGak5qZGhNMkptWkRKbCIsInQiOiJrXC94ZXF2WTU2TkNiendaYzVpcmxiR0oxTzVLaDF3c1wvRG1jWTZYcld4WXNFSnFLbGxiaGdFTlFyeThjcHEzeW5IWVVjT2pDamNVaFVlV01OVmlIa3dvdmRmZENRUVVJTk1vbjlGanhNcDU3d3E2YW5PbTJ4dWpXMlFaanp0UVcxIn0%3D&mrkid=981295

    Any relationship with IMM R&D here...I just wonder....
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
27.5¢
Change
-0.010(3.51%)
Mkt cap ! $400.0M
Open High Low Value Volume
28.0¢ 28.3¢ 27.0¢ $1.034M 3.758M

Buyers (Bids)

No. Vol. Price($)
12 98156 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 85523 9
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.